Key Takeaways
- Worldwide, cleft lip with or without cleft palate occurs in approximately 1 in 700 live births.
- In the United States, about 2,650 babies are born with cleft lip (with or without cleft palate) each year.
- The incidence of cleft lip and palate is higher in Asian populations at 1.5-2 per 1,000 births compared to 1 per 1,000 in Caucasian populations.
- Maternal smoking increases cleft lip risk by 1.3-fold.
- Folic acid deficiency raises cleft lip odds by 2.5 times.
- Diabetes in pregnancy increases cleft lip risk by 8-fold.
- Ultrasound detects 75% of cleft lips prenatally at 18-20 weeks.
- 90% of isolated cleft lips are visible on 3D ultrasound.
- Simonart's band is present in 60% of unilateral cleft lips.
- Primary lip repair surgery is performed at 3-6 months in 95% of cases.
- Rotation advancement flap is used in 70% of unilateral cleft lip repairs.
- Alveolar bone grafting success rate is 90% at 9-11 years.
- Speech intelligibility reaches 90% by age 5 with therapy.
- Hearing loss affects 30% of cleft lip patients long-term.
- Dental anomalies occur in 50% of patients with cleft lip.
Cleft lip is a common but variable birth defect treatable with modern surgical care.
Clinical Characteristics and Diagnosis
- Ultrasound detects 75% of cleft lips prenatally at 18-20 weeks.
- 90% of isolated cleft lips are visible on 3D ultrasound.
- Simonart's band is present in 60% of unilateral cleft lips.
- Bilateral cleft lips occur in 45% of cases with palate involvement.
- Nasal deformity accompanies 100% of cleft lips at birth.
- Genetic testing identifies syndromes in 30% of cleft lip cases.
- Feeding difficulties affect 80% of newborns with cleft lip.
- MRI confirms associated brain anomalies in 10% of cases.
- Pierre Robin sequence co-occurs in 15% of cleft lip patients.
- Ear anomalies are seen in 25% of cleft lip cases.
- 2D ultrasound sensitivity for cleft lip 50%.
- Unilateral cleft lip 70% left-sided.
- Vermilion notching in 80% untreated cleft lips.
- Columella hypoplasia in 100% bilateral cases.
- 20% have associated limb defects.
- Chromosomal anomalies in 10% syndromic clefts.
- 50% have eustachian tube dysfunction at birth.
- Amniocentesis diagnostic in 95% genetic cases.
- Micrognathia in 12% cleft lip infants.
- Heart defects co-occur in 8%.
- Fetal MRI sensitivity 95% for cleft lip.
- Right-sided unilateral 30%.
- Shelf-like projection in 50% bilateral.
- Prolabium in all bilateral clefts.
- Van der Woude syndrome 5%.
- TP63 mutations 1-2%.
- Middle ear effusion 70% newborns.
- CVS diagnostic yield 98%.
- Glossoptosis 10%.
- Limb reduction defects 3%.
Clinical Characteristics and Diagnosis Interpretation
Etiology and Risk Factors
- Maternal smoking increases cleft lip risk by 1.3-fold.
- Folic acid deficiency raises cleft lip odds by 2.5 times.
- Diabetes in pregnancy increases cleft lip risk by 8-fold.
- Family history accounts for 30% of cleft lip cases.
- Paternal age over 40 elevates cleft lip risk by 1.5 times.
- Alcohol consumption during pregnancy doubles cleft lip risk.
- Retinoic acid exposure (vitamin A derivatives) increases risk 10-fold.
- First-degree relatives have 3-5% recurrence risk for cleft lip.
- BMI over 30 in mothers raises cleft lip risk by 1.2 times.
- Antiepileptic drugs like phenytoin increase risk by 4 times.
- Maternal obesity (BMI>30) OR 1.25 for cleft lip.
- Caffeine >300mg/day increases risk by 1.3 times.
- Valproic acid exposure OR 6.5 for cleft lip.
- MSX1 gene mutations in 2% of familial cleft lips.
- Advanced maternal age >35 OR 1.2.
- Hypoxia in pregnancy raises risk 2-fold.
- Pesticide exposure OR 1.5-2.0.
- Recurrent risk for siblings 4% if one affected.
- Nitrosamine exposure in water OR 1.8.
- Multifactorial inheritance model fits 70% cases.
- Folate supplementation reduces risk 25%.
- Opioid use in pregnancy OR 1.9.
- Carbamazepine OR 3.0., source topiramate OR 2.5.
- IRF6 gene variants in 12% cases.
- Paternal smoking OR 1.4.
- Infection risk OR 1.6.
- Solvent exposure OR 2.2.
- Monozygotic concordance 40-60%.
- Assisted reproduction OR 1.3.
- Environmental 70%, genetic 30% model.
Etiology and Risk Factors Interpretation
Long-term Outcomes and Complications
- Speech intelligibility reaches 90% by age 5 with therapy.
- Hearing loss affects 30% of cleft lip patients long-term.
- Dental anomalies occur in 50% of patients with cleft lip.
- Facial growth asymmetry persists in 40% post-surgery.
- Psychological distress reported in 25% of adolescents with repaired cleft lip.
- Employment rates are 10% lower for adults with visible cleft scars.
- Velopharyngeal insufficiency in 15% after lip repair alone.
- Fistula recurrence rate is 5-10% post palatoplasty.
- Life expectancy is normal for isolated cleft lip patients.
- Suicide risk is 2 times higher in cleft patients.
- 70% report good quality of life post multidisciplinary care.
- Nasal regurgitation decreases to 5% post-repair.
- Otitis media risk 50% higher lifelong.
- Hypodontia in 40% of cleft side teeth.
- Maxillary hypoplasia in 30% untreated.
- Bullying victimization 2.5 times higher.
- Healthcare costs 3x higher than average.
- Speech normal in 75% isolated cleft lip.
- 15% require lifelong orthotics.
- Satisfaction with appearance 80% at age 10.
- Fertility rates normal in adults.
Long-term Outcomes and Complications Interpretation
Prevalence and Incidence
- Worldwide, cleft lip with or without cleft palate occurs in approximately 1 in 700 live births.
- In the United States, about 2,650 babies are born with cleft lip (with or without cleft palate) each year.
- The incidence of cleft lip and palate is higher in Asian populations at 1.5-2 per 1,000 births compared to 1 per 1,000 in Caucasian populations.
- Native American populations have the highest rate of cleft lip at 3.32 per 1,000 live births.
- In Europe, the birth prevalence of cleft lip is around 9.2 per 10,000 births.
- Africa reports lower rates of cleft lip at 0.4-0.6 per 1,000 births.
- Male infants are twice as likely as females to have cleft lip without cleft palate (ratio 2:1).
- Cleft lip alone accounts for 20% of all orofacial clefts.
- In Australia, cleft lip incidence is 1.3 per 1,000 live births.
- Japan has a cleft lip prevalence of 1.9 per 1,000 births.
- In the UK, cleft lip prevalence is 1.1 per 1,000 births.
- South America reports 1.0 per 1,000 cleft lip births.
- Monozygotic twins have 40% concordance for cleft lip.
- Cleft lip is 20% more common in winter births.
- Ireland has high rate at 1.8 per 1,000 births.
- Cleft lip with palate is 1.5 times more common than lip alone.
- Global estimate: 300,000 new cleft lip cases yearly.
- China reports 1.4 per 1,000 cleft lip incidence.
- Scandinavia: 1.6 per 1,000 births for cleft lip.
- In Canada, cleft lip rate 1.2 per 1,000.
- Brazil: 1.2 per 1,000 cleft lip births.
- Dizygotic twins concordance 5%.
- Summer births lower risk by 15%.
- Scotland 1.7 per 1,000 incidence.
- Isolated cleft lip 25% of orofacial clefts.
- Developing countries: underreported 50%.
- India 0.9 per 1,000 births.
- Finland 2.0 per 1,000 cleft lip.
Prevalence and Incidence Interpretation
Treatment and Surgical Interventions
- Primary lip repair surgery is performed at 3-6 months in 95% of cases.
- Rotation advancement flap is used in 70% of unilateral cleft lip repairs.
- Alveolar bone grafting success rate is 90% at 9-11 years.
- Nasoalveolar molding pre-surgery reduces scar width by 50%.
- Speech therapy improves outcomes in 85% of post-repair patients.
- Orthodontic treatment is needed in 60% of cleft lip cases.
- Lip revision surgeries occur in 20-30% of patients by age 18.
- Presurgical orthopedics used in 40% of bilateral cleft lips.
- Rhinoplasty at age 16 achieves 80% patient satisfaction.
- Gingivoperiosteoplasty at 3 months boosts bone formation by 70%.
- Multidisciplinary team care reduces surgeries by 25%.
- 95% of cleft lips achieve good aesthetic results post-primary repair.
- Fisher anatomical subunit repair in 80% centers.
- Millard technique used in 50% unilateral repairs.
- Secondary rhinoplasty needed in 60% by adulthood.
- Speech surgery (pharyngoplasty) in 20%.
- Bone distraction osteogenesis success 85%.
- Laser therapy reduces scars in 70%.
- NAM therapy shortens surgery time by 30%.
- Prosthetic obturators used in 10% adults.
- Team visits average 100 per patient lifetime.
- Cost of care $100,000-$200,000 lifetime.
Treatment and Surgical Interventions Interpretation
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2WHOwho.intVisit source
- Reference 3PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 4EUROCAT-REGISTRYeurocat-registry.euVisit source
- Reference 5NCBIncbi.nlm.nih.govVisit source
- Reference 6MAYOCLINICmayoclinic.orgVisit source
- Reference 7NICHDnichd.nih.govVisit source
- Reference 8AIHWaihw.gov.auVisit source
- Reference 9MEDLINEPLUSmedlineplus.govVisit source
- Reference 10FDAfda.govVisit source
- Reference 11ACOGacog.orgVisit source
- Reference 12CRANIOFACIALTEAMTEXAScraniofacialteamtexas.comVisit source
- Reference 13PLASTICSURGERYplasticsurgery.orgVisit source
- Reference 14GENOMEgenome.govVisit source
- Reference 15FEEDINGAMERICAfeedingamerica.orgVisit source
- Reference 16RAREDISEASESrarediseases.orgVisit source
- Reference 17ASHAasha.orgVisit source
- Reference 18AAOINFOaaoinfo.orgVisit source
- Reference 19ACPA-CPFacpa-cpf.orgVisit source
- Reference 20HEARINGLOSShearingloss.orgVisit source
- Reference 21SMARTSURVEYsmartsurvey.co.ukVisit source
- Reference 22CANADAcanada.caVisit source






